Dinoprostone

prostaglandin E receptor 1 ; Homo sapiens







192 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34822808 Prostaglandin E2 EP receptors in cardiovascular disease: An update. 2022 Jan 1
2 35108767 Prostaglandin E2 receptors as therapeutic targets in renal fibrosis. 2022 Jan 1
3 35356289 Prostaglandin E2 and Receptors: Insight Into Tumorigenesis, Tumor Progression, and Treatment of Hepatocellular Carcinoma. 2022 1
4 35379903 Gut microbiota drives macrophage-dependent self-renewal of intestinal stem cells via niche enteric serotonergic neurons. 2022 Jun 3
5 35598847 A systematic analysis of prostaglandin E2 type 3 receptor isoform signaling reveals isoform- and species-dependent L798106 Gαz-biased agonist responses. 2022 Jul 15 3
6 33053444 Prostaglandin E receptors as targets for ischemic stroke: Novel evidence and molecular mechanisms of efficacy. 2021 Jan 1
7 33309520 PGE2 receptors in detrusor muscle: Drugging the undruggable for urgency. 2021 Feb 1
8 33796403 Combination of EP4 antagonist MF-766 and anti-PD-1 promotes anti-tumor efficacy by modulating both lymphocytes and myeloid cells. 2021 Mar 18 2
9 34405223 [Role of prostaglandin E2 in the modulation of renal water transport]. 2021 Aug 25 1
10 31370727 ER-stressed MSC displayed more effective immunomodulation in RA CD4+CXCR5+ICOS+ follicular helper-like T cells through higher PGE2 binding with EP2/EP4. 2020 May 1
11 31689497 Prostaglandin E2, a postulated mediator of neurovascular coupling, at low concentrations dilates whereas at higher concentrations constricts human cerebral parenchymal arterioles. 2020 Feb 1
12 31820176 Prostaglandins and Bone. 2020 2
13 32088247 Targeting prostaglandin receptor EP2 for adjunctive treatment of status epilepticus. 2020 May 2
14 32547404 Eicosanoids in Cancer: Prostaglandin E2 Receptor 4 in Cancer Therapeutics and Immunotherapy. 2020 2
15 32727851 15-Keto-PGE2 acts as a biased/partial agonist to terminate PGE2-evoked signaling. 2020 Sep 18 1
16 32962984 International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1-4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions. 2020 Oct 2
17 30629897 The role of Cox-2 and prostaglandin E2 receptor EP3 in pancreatic β-cell death. 2019 Apr 2
18 30659898 Androgen induces olfactory expression of prostaglandin E2 receptor Ep1 in the burrow-living fish Bostrychus sinensis. 2019 Apr 2
19 30989466 Involvement of EP2 and EP4 Receptors in Eosinophilic Esophagitis: A Pilot Study. 2019 Oct 1
20 30995899 EP1 receptor is involved in prostaglandin E2-induced osteosarcoma growth. 2019 Aug 20 1
21 31008497 [Role of prostaglandin E2 receptor 4 in cardiovascular diseases]. 2019 Apr 25 1
22 31128092 Involvement of different receptor subtypes in prostaglandin E2-induced contraction and relaxation in the lower esophageal sphincter and esophageal body. 2019 Aug 15 1
23 31218341 [Role of prostaglandin E2 receptor EP4 in the regulation of adipogenesis and adipose metabolism]. 2019 Jun 25 1
24 31368289 [Advances of researches on peripheral PKCε pathway during transformation from acute to chronic pain and possibility of application of electroacupuncture intervention]. 2019 Jul 25 3
25 31393950 The epinephrine-induced PGE2 reduces Na+/K+ ATPase activity in Caco-2 cells via PKC, NF-κB and NO. 2019 2
26 31474101 Clostridium difficile Toxin A Upregulates Bak Expression through PGE2 Pathway in Human Colonocytes. 2019 Oct 28 1
27 31589940 Effects of prostaglandin E2 and D2 on cell proliferation and osteogenic capacity of human mesenchymal stem cells. 2019 Dec 2
28 31703303 Prostaglandin E2 Induces Skin Aging via E-Prostanoid 1 in Normal Human Dermal Fibroblasts. 2019 Nov 7 4
29 31835815 Prostaglandin E2/EP Signaling in the Tumor Microenvironment of Colorectal Cancer. 2019 Dec 11 1
30 29129801 Activating prostaglandin E2 receptor subtype EP4 increases secreted mucin from airway goblet cells. 2018 Feb 2
31 29408043 Selectively targeting prostanoid E (EP) receptor-mediated cell signalling pathways: Implications for lung health and disease. 2018 Apr 2
32 29891646 mPGES-1 (Microsomal Prostaglandin E Synthase-1) Mediates Vascular Dysfunction in Hypertension Through Oxidative Stress. 2018 Aug 1
33 29956615 Roles of Cyclooxygenase, Prostaglandin E2 and EP Receptors in Mucosal Protection and Ulcer Healing in the Gastrointestinal Tract. 2018 2
34 31938347 CD44high/ESAlow squamous cell carcinoma cell-derived prostaglandin E2 confers resistance to 5-fluorouracil-induced apoptosis in CD44high/ESAhigh cells. 2018 1
35 27506873 Structural features of subtype-selective EP receptor modulators. 2017 Jan 1
36 28560401 Prostaglandin E2 promotes human CD34+ cells homing through EP2 and EP4 in vitro. 2017 Jul 2
37 28701311 PGE2 upregulates renin through E-prostanoid receptor 1 via PKC/cAMP/CREB pathway in M-1 cells. 2017 Oct 1 1
38 28842681 Cyclooxygenase-2 contributes to oxidopamine-mediated neuronal inflammation and injury via the prostaglandin E2 receptor EP2 subtype. 2017 Aug 25 2
39 28856805 Reactive astrocyte COX2-PGE2 production inhibits oligodendrocyte maturation in neonatal white matter injury. 2017 Dec 3
40 28963072 Prostaglandin E2 restrains human Treg cell differentiation via E prostanoid receptor 2-protein kinase A signaling. 2017 Nov 2
41 29186911 Prostaglandin E2 in the Regulation of Water Transport in Renal Collecting Ducts. 2017 Nov 27 1
42 26300003 Dysregulated CRTC1 activity is a novel component of PGE2 signaling that contributes to colon cancer growth. 2016 May 19 2
43 26328537 Pathophysiological Roles of Cyclooxygenases and Prostaglandins in the Central Nervous System. 2016 Sep 2
44 27060485 Preferred recycling pathway by internalized PGE2 EP4 receptor following agonist stimulation in cultured dorsal root ganglion neurons contributes to enhanced EP4 receptor sensitivity. 2016 Jun 21 2
45 27257388 Upregulation of Cyclooxygenase-2/Prostaglandin E2 (COX-2/PGE2) Pathway Member Multiple Drug Resistance-Associated Protein 4 (MRP4) and Downregulation of Prostaglandin Transporter (PGT) and 15-Prostaglandin Dehydrogenase (15-PGDH) in Triple-Negative Breast Cancer. 2016 2
46 27654511 Cyclooxygenase-2 induced β1-integrin expression in NSCLC and promoted cell invasion via the EP1/MAPK/E2F-1/FoxC2 signal pathway. 2016 Sep 22 3
47 27824617 Tumor-associated macrophages induce vasculogenic mimicry of glioblastoma multiforme through cyclooxygenase-2 activation. 2016 Dec 20 1
48 27871289 Inhibition of STAT3- and MAPK-dependent PGE2 synthesis ameliorates phagocytosis of fibrillar β-amyloid peptide (1-42) via EP2 receptor in EMF-stimulated N9 microglial cells. 2016 Nov 21 1
49 25220136 Hydrogen peroxide stimulation of CFTR reveals an Epac-mediated, soluble AC-dependent cAMP amplification pathway common to GPCR signalling. 2015 Jan 1
50 25433169 Multiple drug resistance-associated protein 4 (MRP4), prostaglandin transporter (PGT), and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) as determinants of PGE2 levels in cancer. 2015 Jan-Mar 1